Breaking News
Sort by:
Top Post
Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]
Verily Opens New R&D Center in Israel Focused on the Application of AI in Healthcare
Verily, an Alphabet company founded at the convergence of healthcare, data science and technology, today […]
Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd.
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced […]
Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline
Exscientia today announced the opening of a 21,000 square foot expansion of its facilities at […]
Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug […]
AI Tool Promises a Breakthrough in Medical Science
A group of British AI researchers have used a computer programme named Alphafold to predict […]
Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
Implicity, a leader in remote patient monitoring software and cardiac data management solutions, announced the […]
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round
Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]
Heru Bolsters Executive Team with Seasoned Industry Veterans
Heru Inc., the developer of wearable AI-powered vision diagnostics and augmentation software, has expanded its […]
Entos Raises $53 Million Series A Round Led by Coatue and Catalio
Entos, Inc (“Entos” or “the Company”), the creator of a cutting-edge platform combining AI-driven technology […]
Exscientia Accelerates COVID-19 Drug Discovery Using AI
Exscientia has received a grant from the Bill & Melinda Gates Foundation and Gates Philanthropy […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more